Why the study?
Does extracellular superoxide dismutase (EC-SOD) deficiency exacerbate angiotensin II-induced hypertension and renal oxidative stress in mice?
Does extracellular superoxide dismutase (EC-SOD) deficiency exacerbate angiotensin II-induced hypertension and renal oxidative stress in mice?
Answers are grounded in this paper and cite their sources.
While EC-SOD protects normal mice against oxidative stress and hypertension, its absence during chronic Ang II infusion leads to a compensatory upregulation of Cu/Zn-SOD that prevents excessive renal oxidative stress and further blood pressure elevation.
Low rates of angiotensin II (Ang II) infusion raise blood pressure, renal vascular resistance (RVR), NADPH oxidase activity, and superoxide. We tested the hypothesis that these effects are ameliorated by extracellular superoxide dismutase (EC-SOD). EC-SOD knockout (-/-) and wild type (+/+) mice were equipped with blood pressure telemeters and infused subcutaneously with Ang II (400 ng/kg per minute) or vehicle for 2 weeks. During vehicle infusion, EC-SOD -/- mice had significantly (P<0.05) higher MAP (+/+: 107+/-3 mm Hg versus -/-: 114+/-2 mm Hg; n=11 to 14), RVR, lipid peroxidation, renal cortical p22(phox) expression, and NADPH oxidase activity. Ang II infusion in EC-SOD +/+ mice significantly (P<0.05) increased MAP, RVR, p22(phox), NADPH oxidase activity, and lipid peroxidation. Ang II reduced SOD activity in plasma, aorta, and kidney accompanied by reduced renal EC-SOD expression. During Ang II infusion, both groups had similar values for MAP (+/+ Ang II: 125+/-3 versus -/- Ang II: 124+/-3 mmHg; P value not significant), RVR, NADPH oxidase activity, and lipid peroxidation. SOD activity in the kidneys of Ang II-infused mice was paradoxically higher in EC-SOD -/- mice (+/+: 8.8+/-1.2 U/mg protein(-1) versus -/-: 13.7+/-1.6 U/mg protein(-1); P<0.05) accompanied by a significant upregulation of mRNA and protein for Cu/Zn-SOD. In conclusion, EC-SOD protects normal mice against oxidative stress by attenuating renal p22(phox) expression, NADPH oxidase activation, and the accompanying renal vasoconstriction and hypertension. However, during an Ang II slow pressor response, renal EC-SOD expression is reduced and, in its absence, renal Cu/Zn-SOD is upregulated and may prevent excessive Ang II-induced renal oxidative stress, renal vasoconstriction, and hypertension.
No takes yet. Share an insight, caveat, or question.
Welch et al. (2006) studied Angiotensin II-induced hypertension and oxidative stress. Angiotensin II infusion vs. vehicle was evaluated on Mean arterial pressure (MAP) during vehicle infusion (p=<0.05).
Synapse has enriched 10 related papers. Consider them for comparative context: